Delivery of oxaliplatin to colorectal cancer cells by folate-targeted UiO-66-NH2
Authors:
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 423, 115573
Abstract
No abstract availableKeywords
Funding Information
- Iran National Science Foundation
- NIMAD
This publication has 87 references indexed in Scilit:
- A review of current nanoparticle and targeting moieties for the delivery of cancer therapeuticsEuropean Journal of Pharmaceutical Sciences, 2013
- Disclosing the Complex Structure of UiO-66 Metal Organic Framework: A Synergic Combination of Experiment and TheoryChemistry of Materials, 2011
- Nanoparticle coronas take shapeNature Nanotechnology, 2010
- Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles – opportunities & challengesNanoscale, 2010
- Biodegradable therapeutic MOFs for the delivery of bioactive moleculesChemical Communications, 2010
- Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of OxaliplatinJournal of the American Chemical Society, 2010
- Folate receptor alpha as a tumor target in epithelial ovarian cancerGynecologic Oncology, 2008
- Folate receptor overexpression is associated with poor outcome in breast cancerInternational Journal of Cancer, 2007
- Essential properties of drug-targeting delivery systemsDrug Discovery Today, 2005
- The folate receptor in central nervous system malignancies of childhoodJournal of Neuro-Oncology, 1994